Loading
Management of Metastatic Bone Disease · Journal article
Cancers · August 18, 2026
A consensus or society position rather than new primary data.
This is a narrative review of surgical management options for recurrent brain metastases, covering repeat resection, laser interstitial thermal therapy (LITT), and intracavitary brachytherapy. The authors acknowledge that management is not well standardized and varies case-by-case, and call for further study to define the role of each approach. No quantitative synthesis or comparative effectiveness data are presented.
Narrative review. Cancer patients with recurrent brain metastases.
Repeat resection can offer rapid improvement in neurological symptoms, performance status, and potentially survival LITT is less invasive than standard craniotomy and offers directed local treatment with tissue diagnosis capability and acceptable survival outcomes Intracavitary brachytherapy allows highly conformal radiation delivery with excellent local control and low rates of radiation necrosis, even in previously irradiated patients
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies three surgical or interventional options available for recurrent brain metastases but does not provide quantitative evidence to guide selection among them. Clinicians should recognize that choice remains individualized pending further comparative studies.
A narrative review synthesizing current surgical management options for recurrent brain metastases, offering clinical recommendations but not reporting original efficacy data or comparative outcomes.
As stated by the source record.
This review identifies three surgical or interventional options available for recurrent brain metastases but does not provide quantitative evidence to guide selection among them. Clinicians should recognize that choice remains individualized pending further comparative studies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
As survival for cancer patients improves, the incidence of brain metastases has risen. This is likely due to improved systemic disease control, increased diligence in surveillance imaging in high-risk pathologies, improved neuro-imaging techniques and increased systemic screening for clinical trial enrollment. While there are well-established treatments for brain metastases, many patients will experience recurrence after definitive treatment. The management of these recurrent lesions is not well established and often varies on a per-patient basis, owing to the clinical complexity and variety of these patients. Patients with recurrent brain metastases have surgical procedural options to achieve local tumor control, including laser interstitial thermal therapy (LITT) repeat open surgical resection with or without placement of intracavity brachytherapy. Repeat resection can offer rapid improvement in neurological symptoms, performance status, and potentially survival. LITT is less invasive than a standard craniotomy but offers a chance at directed local treatment while still obtaining tissue for diagnostic purposes and achieving acceptable survival outcomes. Further study is needed to determine the role of LITT for recurrent brain metastases, but it is a useful tool, particularly for patients with deep-seated lesions who may not tolerate a large surgery. Intracavitary brachytherapy allows for the immediate delivery of highly conformal radiation to the surgical bed with excellent local control and low rates of radiation necrosis, even in previously irradiated patients. The decision regarding which of the above to employ for recurrent brain metastases will vary on a case-by-case basis, and further studies are needed to standardize their use for this growing problem.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.